Optimizating The Expression Of A Recombinant Anti-CD20 IgG For The Treatment Of Canine Lymphoma

Ball, Kathryn (Principal Investigator)
Argyle, David (Co-investigator)
Hupp, Ted (Co-investigator)
Parys, Maciej (Co-investigator)

Status	Finished
Effective start/end date	1/08/18 → 31/07/19

Funding

BBSRC: £15,500.00

1 Article

Hydrogen Deuterium Exchange Mass Spectrometry identifies the dominant paratope in CD20 antigen binding to the NCD1.2 monoclonal antibody
Uhrik, L., Hernychova, L., Muller, P., Kalathiya, U., Lisowska, M. M., Kocikowski, M., Parys, M., Faktor, J., Nekulova, M., Nortcliffe, C., Zatloukalova, P., Ruetgen, B., Fahraeus, R., Ball, K. L., Argyle, D. J., Vojtesek, B. & Hupp, T., 13 Jan 2021, In: Biochemical Journal. 478, 1, p. 99-120
Research output: Contribution to journal › Article › peer-review

Open Access
File